Endpoints News ranks all 57 players in the Covid-19 vaccine race. Here's how it stacks up today
(This piece was last updated on April 16. Endpoints News will continue to track the latest developments through the FDA’s marketing decisions.)
The 57 players now in or close to the clinical race to get a Covid-19 vaccine over the finish line are angling for a piece of a multibillion-dollar market. And being among the leaders now behind Pfizer/BioNTech and Moderna will play a big role in determining just how big a piece.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 107,000+ biopharma pros reading Endpoints daily — and it's free.